Not applicableStudy completedNCT04176354What this trial is testingReal-world Treatment Patterns and Effectiveness of Palbociclib and AI TherapyWho this might be right forMetastatic Breast Cancer Pfizer 813
Testing effectiveness (Phase 2)UnknownNCT05268666What this trial is testingOrally Administered JBI-802, an LSD1/HDAC6 Inhibitor, in Patients With Advanced Solid TumorsWho this might be right forLocally Advanced Solid TumorMetastatic Solid Tumor Jubilant Therapeutics Inc. 126
Testing effectiveness (Phase 2)Ended earlyNCT04659603What this trial is testingTusamitamab Ravtansine Monotherapy and in Combination in Patients With CEACAM5-positive Advanced Solid TumorsWho this might be right forBreast Cancer MetastaticPancreatic Carcinoma Metastatic Sanofi 50
Early research (Phase 1)Study completedNCT01295827What this trial is testingStudy of Pembrolizumab (MK-3475) in Participants With Progressive Locally Advanced or Metastatic Carcinoma, Melanoma, or Non-small Cell Lung Carcinoma (P07990/MK-3475-001/KEYNOTE-001)Who this might be right forCancer, Solid Tumor Merck Sharp & Dohme LLC 1,260
Testing effectiveness (Phase 2)Ended earlyNCT02067741What this trial is testingCR1447 in Endocrine Responsive-HER2neg and TN-ARpos Breast CancerWho this might be right forMetastatic Breast AdenocarcinomaBreast Cancer Swiss Cancer Institute 29
Early research (Phase 1)Study completedNCT01327313What this trial is testingEMD525797 in Solid Tumor Patients in JapanWho this might be right forSolid Tumor Merck KGaA, Darmstadt, Germany 27
Testing effectiveness (Phase 2)WithdrawnNCT06006286What this trial is testingA Study Evaluating Atezolizumab and Bevacizumab Plus ADI-PEG 20 in Patients With Locally Advanced / Metastatic Hepatocellular CarcinomaWho this might be right forMetastatic Hepatocellular Carcinoma M.D. Anderson Cancer Center
Testing effectiveness (Phase 2)Looking for participantsNCT06776770What this trial is testingA Phase Ib/II Study of Adebrelimab in Combination with Capecitabine and Oxaliplatin in CancerWho this might be right forGastric Cancer Cancer Hospital Chinese Academy of Medical Science, Shenzhen Center 52
Early research (Phase 1)UnknownNCT05554666What this trial is testingASKG315 in Patients With Advanced Solid Tumors.Who this might be right forAdvanced Solid Tumors AskGene Pharma, Inc. 56
Early research (Phase 1)Looking for participantsNCT06217822What this trial is testingFirst-in-human Study of 225Ac-PSMA-Trillium (BAY 3563254) in Participants With Advanced Metastatic Castration-resistant Prostate Cancer (mCRPC)Who this might be right forAdvanced Metastatic Castration-resistant Prostate CancerProstate Specific Membrane Antigen (PSMA) Expression Bayer 198
Large-scale testing (Phase 3)Active Not RecruitingNCT04950322What this trial is testingA Trial of SHR1701 Plus Chemotherapy in Patients With Gastric or Gastroesophageal CancerWho this might be right forGastric or Gastroesophageal Junction Cancer Suzhou Suncadia Biopharmaceuticals Co., Ltd. 737
Testing effectiveness (Phase 2)Study completedNCT01635270What this trial is testingPhase 2 Study Evaluating Mid-position Strategy in Radiotherapy Treatment for Patients With a Locally Advanced Non-small Cell Lung CarcinomaWho this might be right forNon-small Cell Lung CancerRadiation TherapyLocally Advanced Disease+2 more Centre Leon Berard 54
Testing effectiveness (Phase 2)Ended earlyNCT03815942What this trial is testingVAccination in Early and ADvanced Prostate caNCErWho this might be right forIntermediate Risk Prostate CancerCastration-resistant Prostate Cancer University of Oxford 23
Testing effectiveness (Phase 2)Active Not RecruitingNCT06381154What this trial is testingPhotoradiation With Verteporfin to Facilitate Immunologic Activity of Pembrolizumab in Unresectable, Locally Advanced or Metastatic Pancreatic CancerWho this might be right forLocally Advanced Pancreatic AdenocarcinomaMetastatic Pancreatic AdenocarcinomaStage II Pancreatic Cancer AJCC v8+3 more Mayo Clinic 24
Testing effectiveness (Phase 2)Looking for participantsNCT06471205What this trial is testingBL-B01D1+PD-1 Monoclonal Antibody in Patients With Unresectable Locally Advanced or Recurrent Metastatic Triple-negative Breast CancerWho this might be right forTriple-negative Breast Cancer Sichuan Baili Pharmaceutical Co., Ltd. 52
Testing effectiveness (Phase 2)Study completedNCT00282022What this trial is testingVNP40101M in Treating Patients With Relapsed or Refractory Locally Advanced or Metastatic Small Cell Lung CancerWho this might be right forLung Cancer Vion Pharmaceuticals 87
Testing effectiveness (Phase 2)UnknownNCT02504229What this trial is testingDC-CIK In Combination With Chemotherapy ( Gio / Oxaliplatin or Cisplatin ) Versus First-line Chemotherapy for Locally Advanced Unresectable or Metastatic Gastric Adenocarcinoma Randomized Controlled Phase II Clinical Study of TreatmentWho this might be right forGastric Cancer Beijing Biohealthcare Biotechnology Co.,Ltd 80
Large-scale testing (Phase 3)Study completedNCT00078572What this trial is testingCapecitabine (XELODA) With Or Without Lapatinib (GW572016) For Women With Refractory Advanced or Metastatic Breast CancerWho this might be right forBreast Cancer GlaxoSmithKline 408
Testing effectiveness (Phase 2)Ended earlyNCT02302339What this trial is testingGlembatumumab Vedotin as Monotherapy or in Combination With Immunotherapies in Patients With Advanced MelanomaWho this might be right forMelanoma Celldex Therapeutics 132
Early research (Phase 1)Study completedNCT01531361What this trial is testingVemurafenib With Sorafenib Tosylate or Crizotinib in Treating Patients With Advanced Malignancies With BRAF MutationsWho this might be right forAdvanced Malignant NeoplasmBRAF Gene MutationMetastatic Malignant Neoplasm+2 more M.D. Anderson Cancer Center 46